United Statesus

Lisa Mateo and Tom Keene discuss the week ahead for the markets and your money on this weeks edition of "Bloomberg Money."

Bloomberg's David Gura and Romaine Bostick join Lisa Mateo and Tom Keene on "Bloomberg Money." They discuss this week's US inflation report, Apple's price hike, and the future of social security.

• Micron Technology reported $41.46 billion in quarterly revenue as the firm capitalized on surging data center component demand.
• The semiconductor manufacturer recorded a GAAP net income of $28.24 billion and declared a quarterly dividend of $0.15 per share.
• Global hardware manufacturers must carefully secure raw materials to execute aggressive revenue projections amid volatile enterprise capital expenditures.

Wendy’s exploded up to 42% intraday on June 24, halting for volatility after a viral WallStreetBets post called on traders to “save Wendy’s before it’s too late.”

• Grayscale linked Bitcoin’s long-term outlook to Federal Reserve interest-rate policy, arguing that lower rates could support demand for digital store-of-value assets. 
• The theme connects several major crypto assets through monetary policy, institutional investment flows and growing adoption of exchange-traded products. 
• Persistent inflation, regulatory uncertainty and the risk of higher-for-longer interest rates remain key challenges for the sector. 

• FedEx reported $25 billion in fourth-quarter fiscal 2026 revenue while executing a spin-off of its freight division to consolidate core operations.
• The logistics provider exceeded cost-cutting targets by securing over $1 billion in structural savings and achieving an adjusted earnings per share of $6.60.
• Global transportation firms face mounting pressure to offset mixed profitability trends by heavily reducing capital spending and divesting secondary business units.

• AbbVie agreed to acquire Apogee Therapeutics in a $10.9 billion all-cash transaction, paying a 60% premium to secure a late-stage immunology pipeline.
• The company will pay $135.11 per share, with executives projecting the deal will not become accretive to adjusted earnings until 2032.
• Large pharmaceutical manufacturers face intense capital pressure to acquire unproven, long-acting biologics to offset impending revenue losses from patent expirations.

• Federal authorities are investigating WiseTech Global (ASX:WTC) executive chairman Richard White over visa fraud and human trafficking allegations.
• The ongoing controversy triggered a sharp market sell-off, pulling the WiseTech share price down to $36.88.
• Institutional investors are reassessing sector governance and operational risk amid wider software industry headwinds.

JD Vance has flown into Switzerland to join Donald Trump’s envoys in 60‑day roadmap talks with Iran, after Pakistan and Qatar said negotiations were making “positive progress” on nukes and sanctions.

• Kraken’s FIFA World Cup sponsorship coincides with prediction market trading volumes surpassing US$2 billion across football-related contracts. 
• Sports forecasting activity is being concentrated in blockchain-based and regulated event markets, led by Polymarket and Kalshi. 
• Regulatory uncertainty around prediction markets remains the key challenge as platforms expand into mainstream sporting events.